Viking Yacht Company Adds SphygmoCor for Employee Wellness

Share Article

Advanced tool will help employees better understand cardiovascular risk, track results of lifestyle modifications and other interventions.

News Image
Viking Yacht Company employees will now have access to leading technology for central blood pressure (the blood pressure at the heart) and arterial stiffness measurements which will help better inform their blood pressure management.

AtCor Medical Holdings Limited (ASX:ACG), the developer and marketer of the SphygmoCor® system for advanced hypertension management, today announced that Viking Yacht Company, a leader in semi-custom fiberglass yacht production, has added AtCor Medical’s SphygmoCor XCEL to its employee wellness program.

Steven Marks, DNP, RN, APN, COHN-S, FAAOHN, Administrator of Viking Employee Medical Clinic and Wellness Program said: “We are proud of our employee wellness program. After Mr. Healey, our Chairman & CEO, benefited from the technology through his personal physician, he decided to add SphygmoCor. With this addition, we now have a more advanced tool to help our employees better understand their cardiovascular risk and they can use this important information to track results of lifestyle modifications and other interventions.

Employee health is important for many reasons, including early identification of disease, prevention and wellness initiatives and improved corporate productivity. Our employees already have access to other advanced tests and access to a range of on-site healthcare professionals. SphygmoCor is another example of a leading medical technology that will contribute to our employees’ long-term health.”

Through SphygmoCor, Viking Yacht Company employees will now have access to leading technology for central blood pressure (the blood pressure at the heart) and arterial stiffness measurements which will help better inform their blood pressure management.

AtCor Medical CEO Duncan Ross said, “We are very pleased that SphygmoCor has become part of Viking Yacht’s investment in employee health and wellbeing. While we have sold SphygmoCor to several executive health practitioners, this is our first sale to a corporate wellness program which allows all employees to benefit.

Corporate wellness is an emerging part of the clinical market and, we believe, an important growth segment as companies seek to reduce employee absenteeism, illness and injuries. Employee well-being programs benefit productivity in the workplace and better health contributes to reducing healthcare costs for both employees and employers.”

SphygmoCor is increasingly being adopted in clinical practice for advanced hypertension management in the U.S. Central arterial pressure waveform analysis, which SphygmoCor provides, is reimbursable using CPT code 93050.

About AtCor Medical
AtCor Medical develops and markets products for the early detection of target organ damage and management of cardiovascular and renal disease. Its technology allows researchers and clinicians to noninvasively measure the central arterial pressure waveform, central aortic pressures and pulse wave velocity. Central arterial pressure waveform analysis, as measured by the company’s SphygmoCor® system, provides clinicians with better prognostic and diagnostic information to determine the need for and type of interventions, effects which cannot be detected with standard brachial blood pressure measurements. SphygmoCor® is essential for hypertension diagnosis and management.

More than 4,000 SphygmoCor® systems are currently in use worldwide at major medical institutions, research institutions and in various clinical trials with leading pharmaceutical companies. The company’s technology has been featured in over 1,000 peer-reviewed studies published in leading medical journals and thousands of citations. AtCor Medical has operations in Australia, the United States, and Europe. For further information, please visit our web site at http://www.atcormedical.com.

About Viking Yacht Company
The Viking Yacht Company has celebrated over five decades in business building luxury performance sport fishing and cruising yachts. Started by brothers Bob and Bill Healey in 1964 when they bought Peterson-Viking Builders, a small, struggling New Jersey builder of 37-foot wooden sport fishing boats, Viking Yachts has grown to become a world leader in semi-custom fiberglass yacht production with over 4,000 Vikings delivered. Viking prides itself on renowned manufacturing capabilities. From the initial design to the finished product, Viking’s highly-regarded reputation is rooted in the company’s commitment to produce 90 percent of the boat in-house by its talented workforce.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mary Hoxworth
AtCor Medical
+1 (206) 861-3805
Email >
@AtCorMedical
since: 01/2013
Follow >
AtCor Medical

Visit website